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Abstract 
  
Cyclophosphamide (CPA) is an effective chemotherapeutic agent, but has side 
effect, causing DNA damage (genotoxic). Papaya leaf (Carica papaya L.) is known has 
flavonoid compound, quercetin. Quercetin is known has DNA protecting effect 
(antigenotoxic effect) by metabolism modulation. Thus, the aim of this research is to 
investigate the antigenotoxic effect of ethanolic extract of papaya (Carica papaya L.) leaf 
(EEPL) on CPA induced mice. The antigenotoxic effect was evaluated by mammalian in vivo 
micronucleus test. EEPL was orally administered as single treatment at dose 1000 mg/kgBW 
and in combination with CPA 50 mg/kgBW at dose 250 mg/kgBW; 500 mg/kgBW; and 1000 
mg/kgBW. Molecular docking using PLANTS on CYP3A4 was performed to explore the 
antigenotoxic effect mechanism. The three different combination dose of EEPL with CPA 
significantly (p<0.05) decreased the amount of micronucleated polychromatic erytrhocyte 
(MNPCE)/1000 polychromatic erythrocyte (PCE) and also increased % 
PCE/(PCE+normochromatic erythrocyte (NCE), compared with single dose of CPA. 
Nevertheless, the antigenotoxic effect wasn’t significant compared with each combination 
dose. The docking score result showed quercetin (-82,41) has more potent interaction to 
CYP3A4 than cyclophosphamide (-70,16) and both of them has similar active site at amino 
acid residue Ile 369 and Thr 309. The results obtained indicated that EEPL at dose 250 
mg/KgBB is the optimal dose as antigenotoxic agent by interaction between quercetin with 
CYP3A4 based on molecular docking.  
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INTRODUCTION 
 
Genotoxic effect is an effect of DNA 
damage that caused by chemical and physical 
agent that can modify nucleotide base and sugar 
phosphate backbone from DNA (Kastan, et al., 
2004). One of the genotoxic agents is 
cyclophosphamide. This genotoxic effect 
caused by the activation of cyclophosphamide 
into its toxic metabolite, that is phosphoramide 
mustard (PM) (Shukla, et al., 2001).  
 One of the natural materials that has 
potency as antigenotoxic agent is Papaya leaves 
(Carica papaya L.). The methanolic extract of 
Papaya leaves contain quercetin 0.04 mg/g of 
dry leaves (Canini, et al., 2007). That have 
antigenotoxic effect by modulation of 
metabolism (Srinivas, et al., 2013). Thus, this 
study will explore the potency of ethanolic 
extract of Papaya leaves (EEPL) as the 
antignotoxic agent. Development of this study 
is mammalian in vivo micronucleus test to see 
the antigenotoxic potency of EEPL and 
molecular docking to observed the interaction 
between quercetin and CYP3A4 enzyme in 
inhibiting the formation of toxic metabolite of 
cyclophosphamide. The data resulted can be 
used to develop papaya leaves as one of the 
antigenotoxic agents to treat of genotoxic 
effect.  
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This study is aimed to develop of EEPL as the 
potencial antigenotoxic agent that useful for 
repairing DNA damage that caused by side 
effect of chemotherapy. 
 
MATERIAL AND METHODS 
 
 Collection and Plant Identification  
The material of this study is papaya 
leaves from Grogol village, Salatiga, Central 
Java, and determined at Pharmaceutical 
Biology Department, Faculty of Pharmacy 
Universitas Gadjah Mada. About 400 g 
powders of papaya leaves was extracted by 
maceration method using 4 litres of ethanol 
70%. Then that was filtered and taken the 
filtrate. The filtrate was evaporated by rotary 
evaporator until resulted the dry extract. After 
that tested thin layer chromatography (TLC) 
toward the content of quercetin. The stationary 
which is used is silica gel 60 plate F254. Eluent 
or mobile phase consist of toluene:acetic acid: 
formic acid (7:2:1). 
 
In vivo Test with Mammalian In Vivo 
Micronucleus Test 
Female Swiss mice strain aged 6-7 
weeks with body weight 22.5-27.5 g as many as 
42 tails were divided into 7 groups (Table 1). 
All treatment groups were sampling peripheral 
blood through vein of tails at the day-7 of 
treatment, 6 hours after giving CPA. The blood 
specimens were made peripheral blood smear 
preparation on the microscope slides, then 
methanol was fixed for 15 minutes and after 
that painted with Giemsa 10% in PBS pH 6.8 
with incubation time 1 hour. The preparation 
was cleaned using aquadest. After the 
preparation dried, preparation was closed by the 
cover slip using Entellen and observed the 
MNPCE, PCE, and NCE under microscope 
with 1000x magnification. 
 
 
Tabel I. Test Animal Treatment 
Group 
  Treatment 
Day-1 Day -2 Day -3 Day -4 Day -5 Day -6 Day -7 
I. Negative 
control 
- - - - - - - 
II. Control of 
EEDP dose 1000 
mg/ Kg BB 
EEDP dose 
1000 mg/ 
Kg BB 
EEDP 
doses 
1000 mg/ 
Kg BB 
EEDP 
doses 
1000 mg/ 
Kg BB 
EEDP dose 
1000 mg/ 
Kg BB 
EEDP 
dose1000 
mg/ Kg BB 
EEDP dose 
1000 mg/ Kg 
BB 
EEDP dose 
1000 mg/ Kg 
BB 
III. Control 
Cyclophosphami
de (CPA) dose 
50 mg/ Kg BB 
- - - - 
 
 
- 
 
CPA dose 50 
mg/ Kg BB 
CPA dose 50 
mg/ Kg BB 
IV. Control of 
solvent CMC-Na CMC-Na CMC-Na CMC-Na CMC-Na 
 
CMC-Na 
 
CMC-Na + 
CPA dose 50 
mg/ Kg BB 
CMC-Na + 
CPA dose 50 
mg/ Kg BB 
V. EEDP dose 
250 mg/ kg BB + 
CPA dose 50 mg/ 
Kg BB 
 
EEDP dose 
250 mg/ Kg 
BB 
 EEDP 
dose 250 
mg/ Kg BB 
EEDP 
dose 250 
mg/ Kg BB 
 EEDP dose 
250 mg/ Kg 
BB 
 
EEDP dose 
250 mg/ Kg 
BB 
 
EEDP dose 
250 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
 EEDP dose 
250 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
VI. EEDP dose 
500 mg/ kg BB + 
CPA dose 50 mg/ 
Kg BB 
 
EEDP dose 
500 mg/ Kg 
BB 
EEDP 
dose 500 
mg/ Kg BB 
EEDP 
dose 500 
mg/ Kg BB 
EEDP dose 
500 mg/ Kg 
BB 
EEDP dose 
500 mg/ Kg 
BB 
EEDP dose 
500 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
EEDP dose 
500 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
VII. EEDP dose 
1000 mg/ kg BB 
+ CPA dose 50 
mg/ Kg BB 
 
EEDP dose 
1000 mg/ 
Kg BB 
EEDP 
dose 1000 
mg/ Kg BB 
EEDP 
dose 1000 
mg/ Kg BB 
EEDP dose 
1000 mg/ 
Kg BB 
EEDP dose 
1000 mg/ 
Kg BB 
EEDP dose 
1000 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
EEDP dose 
1000 mg/ Kg 
BB + CPA 
dose 50 mg/ 
Kg BB 
  
Shabrina, et al., 2017 
Indones. J. Cancer Chemoprevent., 7(1), 31-37  
 
33 
 
Molecular Docking 
Molecular docking was done as final 
confirmation to compare the nterctoin of 
content coumpound of EEDP, quercetin with 
cyclophosphamide made by using Marvin 
Sketch software. While the set of protein 
complex structure was obtained from Protein 
Data Bank (PDB) that downloaded from site 
http://ww.pdb.org/home/home.do.  
 
Data Analysis 
Counted the amount of MNPCE/100 
PCE and % PCE/(PCE+NCE). MNPCE is 
young red blood cells which experienced 
genotoxicity, signed as violet cells which have 
micronucleus like spot. PCE is young red blood 
cells which have no experienced as 
genotoxicity, signed as violet cells but have no 
micronucleus like spot. NCE is mature red 
blood cells, but have no cell coloured violet. In 
genotoxic compound, amount of MNPCE/1000 
PCE is high but amount of %PCE/(PCE+NCE) 
is low.  
Results that obtained of this study were 
analysed with post hoc tukey test with trust 
level 95%. The result of molecular docking was 
docking score between quercetin-CYP3A4 and 
cyclophosphamide- CYP3A4. If docking score 
quercetin-CYP3A4 is lower than 
cyclophosphamide- CYP3A4, it show that 
quercetin which probably contained in the 
EEDP will be potential antigenotoxic agent. 
 
RESULTS AND DISCUSSION 
 
Qualitative Test Results of Active 
Ingredients Compounds 
Test thin layer chromatography (TLC) 
aims to confirm the presence of compounds 
quercetin in EEDP. The system used is silica 
gel G stationary phase and the 60 F254 mobile 
phase mixture of toluene: ethyl acetate: formic 
acid (7:2:1 v / v / v). TLC profile EEDP in seen 
in Fig. 1. 
The result of TLC observed by visible 
light (a), UV 254 nm (b), and UV 366 nm (c) 
shows EEDP and quercetin have the same spot 
hRf at 25. The same value of hRf shows the 
types of compounds that have the same relative 
polarity. This shows great possibilities EEDP 
containing quercetin compounds. 
 
Mammalian In Vivo Test micronucleus 
The Principle of mammalian in vivo 
micronucleus test is the formation of 
micronuclei in the process of hematopoiesis, 
which is one indicator of DNA mutations 
caused by exposure of genotoxic compounds. 
Observations by microscope shows cells with 
MNPCE, PCE and NCE on (Fig. 2). After that, 
count the number of MNPCE/1000 PCE as 
genotoxic parameters and % PCE/PCE + NCE 
as a parameter of toxicity. This study uses 
manually cell counter because of easier, 
cheaper, and has the same accuracy with an 
automated method (Criswell, et al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Profile of thin layer chromatography ethanolic extract of papaya (EEDP). Elution is done with 
the stationary phase silica gel 60 F254 and mobile phase mixture of toluene: ethyl acetate: formic acid (7: 
2: 1). EEDP (1) and quercetin (2) have the same spot on the HRF 25. 
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Figure 2. The appearance blood smear test animals. Peripheral blood smears with Giemsa staining was 
observed through a light microscope with a magnification of 1000x lens (with oil immersion). Black 
arrow (         ) shows an example of each cell MNPCE, PCE, or NCE. 
 
 
Treatment EEDP with combination dose 
250; 500; 1000 mg/KgBW with SIF 
50mg/KgBW can reduce the number of 
MNPCE/1000 PCE significantly (p<0.05) 
compared to treatment SIF, but the decline did 
not differ significantly between treatment dose 
(Fig. 3a). This shows character antigenotoxic of 
EEDP with optimal dose at 250 mg/KgBW of 
2.06 times (Table II). In addition, the 
combination treatment was significantly (p 
<0.05) were able to increase the % PCE/(PCE + 
NCE) compared to treatment SIF, but the 
decline did not differ significantly between 
treatment dose (Fig. 3b). This shows EEDP not  
toxic  at  doses  of  tests  with  optimal doses  at  
250 mg / KgBW  by  1.82 times  (Table 2). 
Overall, the study is same with the 
previous studies showing that some flavonoids 
have been tested in vitro and in vivo has 
antigenotoxic effect (Utesch, et al., 2008). The 
decline Genotoxicity of SIF by EEDP likely 
influenced by interactions of CYP3A4 with 
quercetin thus reducing the formation of 
metabolites genotoksiknya. It also like the 
theory that prevention of mutagenesis can be 
done through a reduction metabolic activity of 
mutagenic compounds (Ruddon, 2007). 
 
 
Table 2.. Changes in the number MNPCE / 1000 PCE and PCE / (PCE + NCE) in test animals 
The treatment group 
MNPCE/ 
1000 PCE 
The 
ratio of 
the 
number 
MNPCE 
PCE/ 
(NCE+PCE) 
Ratio 
%PCE 
Control 15±6.93 - 4.89±0.71 - 
CMC-Na 15±2.65 - 4.23±0.78 - 
EEDP 1000 mg/KgBW  9.67±2.52 - 6±1.35 - 
SIF 50 mg/KgBW 65.33±10.02* - 2.59±0.05* - 
SIF 50 mg/KgBW + EEDP 250 mg/KgBW 31.67±4.04** 2.06 4.73±0.43** 1.83 
SIF 50 mg/KgBW + EEDP 500 mg/KgBW 29±2.65** 2.25 5.14±0.45** 1.98 
SIF 50 mg/KgBW + EEDP 1000 mg/KgBW 23.33±3.06** 2.80 5.69±0.53** 2.19 
the amount shown mean ± SD of three mice 
the ratio is comparation between combination effect and single cyclophosphamide effect 
* p<0.05 compared with controls based on post hoc Tukey test 
** p<0.05 compared with cyclophosphamide treatment based on post hoc Tukey test 
 
MNPCE 
PCE 
NCE 
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Figure 3. Effect EEDP treatment on the profile of peripheral blood smear test animals. Peripheral 
blood smear test animals were observed by light microscope with a magnification of 1000x, then 
calculated the number of MNPCE / 1000 PCE (a), and the% PCE/(PCE + NCE) (b). Significance between 
groups are indicated by numbers on the graph. 
 
 
 
 
 
 
 
 
 
 
Kelompok perlakuan 1 2 3 4 5 6 7 
CMC-Na - + - + + + + 
SIF 50 mg/KgBB - - + - + + + 
EEDP 250 mg/KgBB - - - - + - - 
EEDP 500 mg/KgBB - - - - - + - 
EEDP 1000 mg/KgBB - + - - - - + 
Kelompok perlakuan 1 2 3 4 5 6 7 
CMC-Na - + - + + + + 
SIF 50 mg/KgBB - - + - + + + 
EEDP 250 mg/KgBB - - - - + - - 
EEDP 500 mg/KgBB - - - - - + - 
EEDP 1000 mg/KgBB - + - - - - + 
(a) 
(b) 
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Molecular Docking 
Results docking of CYP3A4 showed that 
quercetin docking score (-82.41) lower than 
cyclophosphamide (-70.16) (Table 3). This 
suggests that quercetin is a more potent when 
interact with CYP3A4 than cyclophosphamide. 
These  results  are  supported  by  visualization 
of interaction shows the similarities between 
the bond  sites  of  quercetin and 
cyclophosphamide on CYP3A4 at Thr Ile 369 
and 309 amino acid residue through  
hydrophobic  bonding (Fig. 4). 
 
CONCLUSION 
 
EEDP have antigenotoxic effects against 
cyclophosphamide and not toxic at the dose test 
with an optimal dose of 250 mg/KgBW. 
Antigenotoxic effect of EEDP was predicted by 
interactions of quercetin compound with 
CYP3A4 at Thr Ile 369 and 309 amino acid 
residue through hydrophobic bond. Thus, 
EEDP can inhibit the metabolism of 
cyclophosphamide into toxic metabolites, i.e, 
phosphoramide mustard. 
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Table 3. Docking scores of quercetin and cyclophosphamide on CYP3A4 
No. Ligand name Docking score RMSD 
1. Quercetin -82,41 3,00 
2. Cyclophosphamide -70,16  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Interaction of cyclophosphamide and quercetin on CYP3A4. Visualization interactions on 
CYP3A4 showed quercetin compound (a) and cyclophosphamide (b) have the same connective site at Thr 
Ile 369 and 309 amino acid residue. The sign     showed the same amino acid residues at the site of 
connective. 
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